Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Victoria non-exec invests, Faron Pharma CFO sells entire holding
(Sharecast News) - Shares in Victoria saw director support on Tuesday, after the group disclosed that non-executive director Steve Callaghan purchased 260,000 ordinary shares at 37.93p each on 9 January. The transaction, carried out on the London Stock Exchange, gave Callaghan a holding of 260,000 shares, representing around 0.23% of the company's issued share capital, according to the regulatory filing.
Separately, Faron Pharmaceuticals reported that its chief financial officer, Jurriaan Dekkers, sold his entire holding of 4,000 ordinary shares at 182.2p per share on 12 January.
Following the sale, which was executed on AIM, Dekkers no longer holds any shares or voting rights in the clinical-stage immunotherapy company.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Victoria (VCP) Director name: Callaghan,Stephen James Amount purchased: 260,000 @ 37.93p Value: £98,618.00
Guardian Metal Resources (GMET) Director name: Starzecki ,J.T Amount purchased: 37,250 @ 149.00p Value: £55,502.50
Lindsell Train Investment Trust (LTI) Director name: Lindsell,Michael Amount purchased: 5,000 @ 648.92p Value: £32,446.13
Guardian Metal Resources (GMET) Director name: Friesen,Oliver Amount purchased: 20,100 @ 148.00p Value: £29,748.00
Bp (BP.) Director name: Howle,Carol Amount purchased: 73 @ 425.60p Value: £310.69
Centrica (CNA) Director name: OÂ'Shea,Chris Amount purchased: 83 @ 180.84p Value: £150.10
Centrica (CNA) Director name: O'Brien,Russell Amount purchased: 83 @ 180.84p Value: £150.10
Sabre Insurance Group (SBRE) Director name: Carter,Geoffrey Richard Amount purchased: 112 @ 133.62p Value: £149.65
Sthree (STEM) Director name: Beach,Andrew Amount purchased: 82 @ 181.81p Value: £149.08
Croda International (CRDA) Director name: Foots,Steve Amount purchased: 5 @ 2,714.00p Value: £135.70
Bp (BP.) Director name: Thomson ,Kate Amount purchased: 5 @ 425.60p Value: £21.28
Top Director Sells
Faron Pharmaceuticals Oy (di) (FARN) Director name: Dekkers,Jurriaan Amount sold: 4,000 @ 182.20p Value: £7,288.00
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
